In this study, we retrospectively reviewed our successfully tested EGFR results for 21,324 unselected Chinese NSCLC patients whose specimens were performed in our laboratory, a College of American Pathologists (CAP)-certified reference laboratory providing EGFR mutation testing for NSCLC patients. This evidence concerns the gene EGFR and non-small cell lung carcinoma.